Geron Corporation (GERN) Financials

GERN Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 534.1 million 305.0 million
Dec. 31, 2025 570.5 million 344.7 million
Sept. 30, 2025 567.4 million 318.7 million
June 30, 2025 555.2 million 295.7 million

GERN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -63.2 million 4.9 million
Dec. 31, 2025 -22.1 million 7.4 million
Sept. 30, 2025 -13.5 million 6.8 million
June 30, 2025 -27.6 million -7.4 million

GERN Net Income

No data available :(

GERN Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 314.3 million 230.2 million 1.2 million
Dec. 31, 2025 359.8 million 231.7 million 2.4 million
Sept. 30, 2025 380.5 million 119.3 million 2.7 million
June 30, 2025 388.0 million 119.0 million 2.9 million

GERN Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 669.4 million
Dec. 31, 2025 667.2 million
Sept. 30, 2025 667.1 million
June 30, 2025 666.2 million

GERN Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 252000 15.0 million 35.4 million -
Dec. 31, 2025 32000 15.8 million 41.7 million -
Sept. 30, 2025 89000 21.1 million 39.0 million -
June 30, 2025 138000 21.7 million 38.6 million -

GERN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 51.8 million 1.7 million
Dec. 31, 2025 48.0 million 1.3 million
Sept. 30, 2025 47.2 million 22.1 million
June 30, 2025 49.0 million 1.2 million

GERN Revenue by Segment
Graph available only for paid members. Upgrade to see it.

GERN

Price: $1.17

52 week price:
1.04
2.01

Earnings Per Share: -0.11 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 535483

Ebitda: -6.9 million

Market Capitalization: 744.2 million

Links: